Mario Gabelli's VRTX Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 512 shares of Vertex Pharmaceuticals Incorporated (VRTX) worth $200,520, representing 0.00% of the portfolio. First purchased in 2025-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Mario Gabelli has initiated a new position in VRTX, representing a fresh investment thesis on this company.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Vertex Pharmaceuticals Incorporated (VRTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vertex Pharmaceuticals Incorporated (VRTX) Trades by Mario Gabelli
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | +512 | New Buy | 512 | $445.20 |
Mario Gabelli's Vertex Pharmaceuticals Incorporated Investment FAQs
Mario Gabelli first purchased Vertex Pharmaceuticals Incorporated (VRTX) in Q2 2025, acquiring 512 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Vertex Pharmaceuticals Incorporated (VRTX) for 2 quarters since Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's largest addition to Vertex Pharmaceuticals Incorporated (VRTX) was in Q2 2025, adding 512 shares worth $227,942. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 512 shares of Vertex Pharmaceuticals Incorporated (VRTX), valued at approximately $200,520. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Vertex Pharmaceuticals Incorporated (VRTX) represents approximately 0.00% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's peak holding in Vertex Pharmaceuticals Incorporated (VRTX) was 512 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.